Rona Samler is a seasoned tech executive with an eye for great ideas, a talent for spearheading innovation, and a passion for building high-growth business.
Rona Samler is the Chief Business Officer of Technion Research & Development Foundation Ltd., Managing Director of T3 – Technion Technology Transfer and CEO of AMIT- Alfred Mann Institute at the Technion.
Leading up to this position, Rona has served as VP of Business Development at Ramot, Tel Aviv University’s technology transfer office, where she initiated and oversaw a long list of investments, licensing agreements, and joint ventures with tech companies in Israel and worldwide.
Previously, she served as Head of Business Development at Syneron Medical (NASDAQ: ELOS); as CEO at Cupola Medical for the Offer Brothers Group’s Naiot Venture Accelerator; and as VP of Global Business at Colbar LifeScience, which was acquired by Johnson & Johnson in 2006 for $160 million.
She graduated summa cum laude in Chemistry at the Technion-Israel Institute of Technology and earned her MBA at Haifa University with highest distinction.